Ishak Lawal from End Cervical Cancer Nigeria Initiative shares lessons learned from a HPV pilot demonstration in Nigeria.
Related content
![](https://www.vaccineconfidence.org/wp-content/uploads/Screenshot-2023-01-24-095501-aspect-ratio-16-9.png)
Overview The global community of practice around HPV vaccination is not formalised to cut across multiple disciplines, and thought leaders from low-…
![](https://www.vaccineconfidence.org/wp-content/uploads/q4u9pyfz-vq-aspect-ratio-16-9.jpg)
Bassey Okposen from the National Primary Health Care Development Agency in Nigeria shares the process and the challenges being faced to…
![](https://www.vaccineconfidence.org/wp-content/uploads/3825529-aspect-ratio-16-9.jpg)
This briefing on HPV and vaccination explains the disproportionate global burden of cervical cancer on Lower Middle Income Countries and the significant barriers in the…
![](https://www.vaccineconfidence.org/wp-content/uploads/ab4azc723ii-aspect-ratio-16-9.jpg)
The slide deck explains the global burden of HPV-related cervical cancer, the current landscape of HPV vaccines,…
![](https://www.vaccineconfidence.org/wp-content/uploads/1_3Tcyuw-2vN9xfFUD9eATSQ-aspect-ratio-16-9-350x197.webp)
Overview The Vaccine Confidence Project at the London School of Hygiene & Tropical Medicine, in partnership with Premise, developed ASSURE – Assessing Signals and Supporting Resilience.
![](https://www.vaccineconfidence.org/wp-content/uploads/cerddu-jwkw-aspect-ratio-16-9-350x197.jpg)
Overview Human Papillomavirus (HPV) is the fourth biggest cause of mortality amongst women in Brazil according to the Pan American Health Organisation (PAHO) but COVID-19…